Condition: Premature Coronary Heart Disease · Sponsor: China National Center for Cardiovascular Diseases
The goal of this clinical trial is to learn if an AI-enabled stratified management system (SMART-CHD) can improve post-discharge outcomes in adults aged 18-45 with premature coronary artery disease. The main questions it aims to answer are: 1. Does SMART-CHD reduce the combined rate of all-cause death, myocardial infarction, stroke and rehospitalization within 12 months? 2. Does SMART-CHD achieve better control of modifiable risk factors compared with usual care? Researchers will compare SMART-CHD to standard discharge management (verbal and printed instructions on medications, follow-up timelines and lifestyle advice) to see if the AI-driven platform leads to fewer adverse events and improved risk-factor profiles. Participants will: 1. Install and use the SMART-CHD mobile app after a 10-minute structured orientation session with supervised simulations. 2. Complete regular in-app surveys on lifestyle behaviors, laboratory/imaging results and clinical events (with OCR-powered LLM assistance). 3. Wear paired sensors for continuous monitoring of blood pressure, heart rate and other physiologic metrics. 4. Receive automated EHR data harvesting, AI-driven voice-call reminders, and real-time CRC support via a dedicated WeChat group. 5. Follow personalized, guideline-based risk-factor recommendations (diet, exercise, sleep, weight, smoking, alcohol, hypertension, dyslipidemia, diabetes).
This description comes directly from the study's public registry record.
Gao Prof. Gao, MD, PhD · 010-88322413 · sophie_gao@sina.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of University of Science and Technology of China | Hefei, Anhui, China | Not Yet Recruiting |
| Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases | Beijing, Beijing Municipality, China | Recruiting |
| Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen | Shenzhen, Guangdong, China | Not Yet Recruiting |
| The First Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| The Second Hospital Of Hebe Medical University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Not Yet Recruiting |
| Henan Provincial Chest Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Zhengzhou University Affiliated Zhengzhou Central Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Zhengzhou University Fuwai Central China Cardiovascular Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Not Yet Recruiting |
| Northern Jiangsu People's Hospital | Yangzhou, Jiangsu, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Xi'an Jiaotong University | Xi'an, Shaanxi, China | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07031531